FIBRINOLYSIS OF ST ELEVATION MYOCARDIAL INFARCTION IN EMERGENCY DEPARTMENT: PROGNOSIS OF ELDERLY PATIENTS TREATED WITH STREPTOKINASE
- Authors
-
-
Hela ben turkia
emergency department regional hospital of Ben Arous
-
Firas chabaane
emergency departement of regional hospital of Ben Arous
-
Syrine Keskes
emergency departement of regional hospital of Ben Arous
-
Ines Chermiti
emergency departement of abderrahmen Mami hospital
-
Rahma Dhokkar
emergency departement of regional hospital of Ben Arous
-
Yosra Majdoub
emergency departement of regional hospital of Ben Arous
-
hanene ghazali
emergency departement of regional hospital of Ben Arous
-
Sami Souissi
emergency departement of regional hospital of Ben Arous
-
- Keywords:
- Thrombolysis, Myocardial infarction, Wall Infarction , Emergency, prognosis
- Abstract
-
The use of fibrinolytic therapy for ST segment elevation myocardial infarction (STEMI) can lead to fatal complications. The streptokinase, a non-specific fibrinolytic, remains used in developing countries. The safety of this fibrinolytic agent is under studied in the elderly population.
AIM: Compare the prognosis of elderly patients (> 75 years old) treated with Streptokinase for STEMI versus 75 years old regard to hemorrhagic complications and mortality.
Methods:
Prospective study (2009-2018). Inclusion of patients treated with Streptokinase for STEMI. Comparison of two groups: elderly patients and less than 75 years old patients.
Results:
Inclusive of 624 patients. Mean age=59±11 years. Sex-ratio=5.
Patients aged more than 75 years represented 10% of the study. The comparative study of elderly group (n=63) versus (vs) patients less than 75 years (n=561) found that elderly patients were more frequently male Sex-ratio = 1 vs 7 (p<0,001) and have more hypertension (59%) vs (25%) (p<0,001). Atypical clinical presentation was more frequent in the elderly group 30% vs 16%. No difference was found in the two groups concerning fibrinolysis success 57% vs 61% and intracranial hemorrhage 0 vs 2 patients. In hospital and one-week mortality were higher in the elderly group with respectively, 4.8% and 8% vs 0.7% and 1.2%.Factors associated with mortality among elderly patients were:
Anterior myocardial infarction (OR=6.37, p=0.044, 95%IC 1.19-34) and cardiogenic shock (OR=38, p<0.001, 95%IC 5.02-287.43).
Streptokinase is an effective therapeutic alternative for elderly with STEMI. It causes reperfusion in 57% of cases with no significant increase of major hemorrhagic events
- Author Biography
- References
- Downloads
- Published
- 25-12-2025
- Section
- Prospective study
- License
-
Copyright (c) 2025 Tunisian Journal of Emergency Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
THE tjem allows authors to retain unrestricted copyright and full publishing rights of their articles.
All articles published in this journal are openly accessible and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This guarantees that anyone is free to:
-
Share: Copy and redistribute the material in any medium or format.
-
Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
Under the following terms:
-
Attribution: Users must give appropriate credit to the original author(s) and the journal, provide a link to the license, and indicate if changes were made.
By submitting a manuscript to tjem, authors grant the journal the right of first publication, while retaining full ownership of their intellectual property.
-
